Quinsair (levofloxacin)

pCPA File Number: 20963
Negotiation Status:
Concluded with an LOI
Indication(s):
Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections
Sponsor/Manufacturer:
Raptor Pharmaceuticals Inc.
CADTH Project Number:
SR0493-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: